0000927066-24-000033.txt : 20240308
0000927066-24-000033.hdr.sgml : 20240308
20240308170433
ACCESSION NUMBER: 0000927066-24-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rodriguez Javier
CENTRAL INDEX KEY: 0001415548
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 24735409
MAIL ADDRESS:
STREET 1: 601 HAWAII ST.
CITY: EL SEGUNDO
STATE: CA
ZIP: 90245
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wk-form4_1709935450.xml
FORM 4
X0508
4
2024-03-06
0
0000927066
DAVITA INC.
DVA
0001415548
Rodriguez Javier
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-03-06
4
M
0
750000
67.80
A
1244480
D
Common Stock
2024-03-06
4
D
0
377646
134.65
D
866834
D
Common Stock
2024-03-06
4
F
0
162905
134.65
D
703929
D
Stock Appreciation Rights
67.80
2024-03-06
4
M
0
750000
0
D
2022-11-04
2024-11-04
Common Stock
750000
750000
D
Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
This award was approved by the Compensation Committee of DaVita's Board of Directors on November 4, 2019, subject to stockholder approval to amend its 2011 Incentive Award Plan ("Plan Amendment"). DaVita's stockholder's approved the Plan Amendment on January 23, 2020. This award vested 50% each on November 4, 2022 and November 4, 2023.
/s/ Stephanie N. Berberich, Attorney-in-Fact
2024-03-08